Background Preeclampsia is a disease with far-reaching consequences that extend beyond
the immediate postpartum period and have a significant impact later in life. Preeclampsia …

The hypertensive disorders of pregnancy are among the leading causes of maternal and
fetal morbidity and mortality. Differentiating these disorders requires careful evaluation of the …

Irrespective of the cause of cardiac arrest, early recognition and calling for help, including
appropriate management of the deteriorating patient, early defibrillation, high-quality …

Preeclampsia/eclampsia is one of the 3 leading causes of maternal morbidity and mortality
worldwide. During the past 50 years, there has been a significant reduction in the rates of …

Preeclampsia is a clinical syndrome defined as the new onset of hypertension and
proteinuria during the second half of pregnancy. 1 It afflicts 3% to 5% of pregnancies and is …

The incidence of pre-eclampsia ranges from 3% to 7% for nulliparas and 1% to 3% for
multiparas. Pre-eclampsia is a major cause of maternal mortality and morbidity, preterm …

Background Robust evidence to direct management of pregnant women with mild
hypertensive disease at term is scarce. We investigated whether induction of labour in …

Preeclampsia, a hypertensive disorder peculiar to pregnancy, is a systemic syndrome that
appears to originate in the placenta and is characterized by widespread maternal …

Worldwide, approximately 300 million people of all ages and ethnic backgrounds have
asthma. 296 T he worldwide prevalence of asthma symptoms ranges from 1 to 18% of the …

Preeclampsia is a systemic syndrome that occurs in 3 to 5% of pregnant women and
classically manifests as new-onset hypertension and proteinuria after 20 weeks of gestation …